The Japan hair loss treatment market size reached USD 282.02 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 597.68 Million by 2033, exhibiting a growth rate (CAGR) of 7.80% during 2025-2033. The market is driven by increasing hair loss among men and women, caused by aging or an altered lifestyle. Moreover, growing awareness about treatment options, both medication and noninvasive procedures, fuels the market expansion. In addition, advancements in technology, research and development (R&D) activities, and the demand for cosmetic procedures are some of the major factors augmenting the Japan hair loss treatment market share.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024
|
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 282.02 Million |
Market Forecast in 2033 | USD 597.68 Million |
Market Growth Rate 2025-2033 | 7.80% |
Increasing Prevalence of Hair Loss
The growing prevalence of hair loss in Japan is one of the key drivers of market growth. As per an industry report, Japan has the highest incidences of alopecia, about 26%, with 7.8% of females experiencing some hair thinning. Besides this, as the population grows older, hair thinning and baldness become a more prevalent condition. This trend exists among the younger population, as well as stress, poor diet, and environmental pollution. Additionally, an increase in lifestyle diseases, such as diabetes and high blood pressure, also hastens hair loss, contributing to the market expansion. Also, hereditary causes contribute heavily, with a large percentage of people suffering from male and female pattern baldness. This growing incidence is creating an increasing demand for efficient solutions, which in turn has created new products and services in the market. Other than this, customers are increasingly turning towards professional treatments, supplements, and over-the-counter remedies, which is providing an impetus to Japan hair loss treatment market growth. With increasing awareness of the causes of baldness, treatments are becoming increasingly popular to overcome this common affliction.
Technological Advancements in Hair Loss Treatments
The market is experiencing an upsurge in technological developments, especially in non-invasive treatments and devices meant for domestic use. Laser therapy, for example, is becoming popular as a non-surgical, FDA-approved treatment for triggering hair growth. Moreover, laser machines are more affordable and reachable, and consumers can incorporate treatment into their daily regimen. Further, breakthroughs in hair transplant technology, such as robotic transplant technology and FUE (Follicular Unit Extraction) procedures, have maximized the accuracy and results of hair restoration treatments. Notably, Shiseido, a prominent multinational cosmetics company in Japan, has led the way in a revolutionary breakthrough in hair regeneration through its S-DSC® therapy. The firm began providing this treatment to patients in Japan on July 1, 2024. The treatment is done by growing a patient's DSCs (dermal stem cells) and injecting them into the scalp to induce hair growth. This new procedure is a landmark in hair restoration technology. These developments shorten recovery time, enhance outcomes, and limit scarring, making them more attractive to patients. In addition, genetic studies are assisting in making treatments more specific to patient's genetic makeup, enhancing their efficacy. The combination of these technologies expands the range of choices and enhances the performance of treatments, once again fueling consumer interest in superior and more advanced solutions. This shift represents the expanding function of technology in redefining the hair loss treatment landscape.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2025-2033. Our report has categorized the market based on product type, type, route of administration, gender, and distribution channel.
Product Type Insights:
The report has provided a detailed breakup and analysis of the market based on the product type. This includes corticosteroids, antihypertensive, topical immune-modulators, and others.
Type Insights:
A detailed breakup and analysis of the market based on the type have also been provided in the report. This includes non cicatricial (telogen effluvium, androgenetic alopecia, and alopecia areata), cicatricial, and others.
Route of Administration Insights:
The report has provided a detailed breakup and analysis of the market based on the route of administration. This includes oral and topical.
Gender Insights:
A detailed breakup and analysis of the market based on the gender have also been provided in the report. This includes male and female.
Distribution Channel Insights:
A detailed breakup and analysis of the market based on the distribution channel have also been provided in the report. This includes hospital pharmacies, retail pharmacies, and online pharmacies.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report |
Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Product Types Covered | Corticosteroids, Antihypertensive, Topical Immune-Modulators, Others |
Types Covered |
|
Route of Administrations Covered | Oral, Topical |
Genders Covered | Male, Female |
Distribution Channels Covered | Hospital Pharmacies, Retail Pharmacies, Online Pharmacies |
Regions Covered | Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, Shikoku Region |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: